Published in Medical Devices and Surgical Technology Week, July 29th, 2007
The monoclonal antibody, produced by GBI to standards fully compliant with both US and European requirements, will be used to kick off the initial phase of a multicenter clinical trial, known around the world as MIMOSA (Monoclonal antibody Immunotherapy for Malignancies of the Ovary by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.